Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-30 @ 12:50 PM
Study NCT ID:
NCT01083368
Status:
COMPLETED
Last Update Posted:
2019-08-21
First Post:
2010-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-05
First Submit QC Date:
None
Study First Post Date:
2010-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-19
Results First Submit QC Date:
None
Results First Post Date:
2019-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-19
Last Update Post Date:
2019-08-21
Last Update Post Date Type:
ACTUAL